Abstracts

Abstract Submission Guidelines
Abstract submission dates will be published in the upcoming weeks on this website.

General guidelines
Abstracts should contain the following four components:

- Background: a concise statement of the issue under investigation or a hypothesis; - Materials & Methods: the experimental methods used (including the statistical analyses employed);
- Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.  The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically using the button on the right. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. 

Topics for abstract submission
Selection of the most appropriate topic is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. 

- Prostate cancer
- Chronic fatigue syndrome/ neuro immune diseases
- Therapeutic / vaccine (animal model)
- Pathogenesis
- Basic virology
- Immune response
- Host restriction factors
- Assay development and screening

Virology Education B.V.
Biltstraat 106
3572 BJ Utrecht
The Netherlands
P: +31 (0)30 230 7140
F: +31 (0)30 230 7148
E: info@virology-education.com

Chamber of Commerce Utrecht, nr 30171841 – VAT Number NL809658380B01